bromfenac has been researched along with Inflammation in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Braglia, L; Cimino, L; Coassin, M; De Maria, M; Fontana, L; Mastrofilippo, V; Sartori, A | 1 |
| Cimino, L; Coassin, M; De Maria, M; Fontana, L; Iannetta, D; Mastrofilippo, V | 1 |
| Cai, M; Cao, Y; Chen, X; Huang, W; Wang, C | 1 |
| Ciulla, T; Harris, A; Price, F; Siesky, B; Wentz, SM | 1 |
| Goldberg, DF; Gow, JA; Peace, JH; Walters, TR | 1 |
| Brookshire, HL; English, RV; Gift, BW; Gilger, BC; Nadelstein, B; Weigt, AK | 1 |
| Bucolo, C; Drago, F; Marrazzo, G; Platania, CB; Romano, GL; Salomone, S | 1 |
| Hoy, SM | 1 |
| Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY | 1 |
| Cable, MG; Chandler, SP; Fong, R; Gow, JA; Klier, SM; McNamara, TR; Peace, JH; Sadri, E; Silverstein, SM | 1 |
| Chandler, SP; Gayton, JL; Gow, JA; Henderson, BA; Klier, SM; McNamara, TR | 1 |
| Holland, EJ; Lane, SS | 1 |
| Jolas, T; Silliman, D; Waterbury, LD | 1 |
| Donnenfeld, ED; Gow, JA; Grillone, LR; Holland, EJ; Stewart, RH | 1 |
| Fukiage, C; Ogawa, T; Sakaue, T; Terai, T | 1 |
2 review(s) available for bromfenac and Inflammation
| Article | Year |
|---|---|
Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Clinical Trials as Topic; Drug Compounding; Humans; Inflammation; Pain, Postoperative; Treatment Outcome | 2019 |
Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Female; Humans; Inflammation; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative | 2015 |
7 trial(s) available for bromfenac and Inflammation
| Article | Year |
|---|---|
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Female; Humans; Inflammation; Italy; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications | 2019 |
Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Double-Blind Method; Eye Pain; Female; Humans; Inflammation; Lens Implantation, Intraocular; Male; Ophthalmic Solutions; Phacoemulsification; Postoperative Care; Prospective Studies; Treatment Outcome; Uveitis | 2014 |
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Female; Humans; Inflammation; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Miosis; Phacoemulsification; Postoperative Complications; Postoperative Period; Premedication; Treatment Outcome | 2015 |
Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Double-Blind Method; Drug Administration Schedule; Eye Diseases; Female; Humans; Inflammation; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Pain, Postoperative; Placebos; Postoperative Complications | 2011 |
Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Endpoint Determination; Eye Pain; Female; Humans; Inflammation; Lens Implantation, Intraocular; Male; Ophthalmic Solutions; Pain, Postoperative; Postoperative Complications; Pseudophakia; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2011 |
Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anterior Chamber; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Topoisomerase II Inhibitors; Uveitis, Anterior; Visual Acuity | 2013 |
Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Female; Humans; Inflammation; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2007 |
6 other study(ies) available for bromfenac and Inflammation
| Article | Year |
|---|---|
Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Female; Humans; Inflammation; Lasers; Macular Edema; Male; Middle Aged; Phacoemulsification; Photometry; Postoperative Complications; Tomography, Optical Coherence | 2020 |
Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract Extraction; Humans; Inflammation; Meta-Analysis as Topic; Ophthalmic Solutions; Postoperative Complications; Systematic Reviews as Topic | 2020 |
Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Celecoxib; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Inflammation; Intraocular Pressure; Lenses, Intraocular; Phacoemulsification; Prednisolone | 2015 |
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cyclooxygenase 2; Dinoprostone; Indomethacin; Inflammation; Lipopolysaccharides; Male; Phenylacetates; Rats, Sprague-Dawley; Retina; Retinal Hemorrhage; Uveitis | 2014 |
Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Activation; Eye Diseases; Humans; Inflammation; Ketorolac Tromethamine; Rabbits; Recombinant Proteins | 2006 |
[Effects of bromfenac sodium, non-steroidal anti-inflammatory drug, on acute ocular inflammation].
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Eye Diseases; Inflammation; Male; Rabbits; Rats; Rats, Wistar | 1995 |